Loading provider…
Loading provider…
Cardiovascular Disease Physician in Granada Hills, CA
NPI: 1730392887Primary Practice Location
Socal Heart Care
10515 N Balboa Blvd, Granada Hills, CA
Primary Employer
Socal Heart Care
socalheart.com
HQ Phone
Get MD Sunil's Phone Numberphone_androidMobile
Get MD Sunil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2025
PA State Medical License
2003 - 2006
Bangalore Medical College
Medical School
Until 2001
Cedars-Sinai Medical Center
Fellowship • Cardiovascular Disease
—
Drexel University College of Medicine/Hahnemann University Hospital
Residency • Internal Medicine
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 712 | 850 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 403 | 2,338 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 368 | 487 |
| 4 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 263 | 758 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 261 | 773 |
Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes.
Authors: Rangappa, Sunil, Fen, Chen, Lee, Eng Hin, Bongso, Ariff, Sim, Eugene Kwang Wei
Journal: Ann Thorac Surg
Authors: Rangappa, Sunil, Entwistle, John W C, Wechsler, Andrew S, Kresh, J Yasha
Journal: J Thorac Cardiovasc Surg
Review article: current status of myocardial regeneration: new cell sources and new strategies.
Authors: James Forrester, James Forrester
Journal: J Cardiovasc Pharmacol Ther
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: OTHER: Placebo, DRUG: Tirzepatide